Ovarian Cancer Research Alliance hosted a free online seminar on April 9th titled “Endometrial Cancer: Understanding Biomarker Testing & Its Value in the Changing Treatment Landscape.” Dr. Ramez Eskander of UC San Diego Moores NCI-Designated Comprehensive Cancer Center and Dr. Ann Klopp of The University of Texas MD Anderson Cancer Center answered questions live, discussing … Continued
Ovarian Cancer Research Alliance’s Vice President of Policy, Chad Ramsey, spoke with Ellen Bryan of WUSA-TV’s Great Day Washington, and shared important new findings from a paper co-authored by OCRA and Komodo Health. The analysis reveals that nearly half of women diagnosed with ovarian cancer don’t receive essential genetic testing, despite its impact on treatment and … Continued
DISPARITIES IN TESTING RATES AMONG OLDER WOMEN AND THOSE ON PUBLIC INSURANCE PERSIST [New York, New York – March 25, 2025] – Nearly half of women diagnosed with ovarian cancer are not receiving the genetic testing that could help guide treatment and improve outcomes, according to a new analysis released today by Ovarian Cancer Research … Continued
Ovarian Cancer Research Alliance’s Vice President of Policy, Chad Ramsey, spoke with Ellen Bryan of WUSA-TV’s Great Day Washington ahead of OCRA’s Advocacy Day on March 25th. Ramsey shared new data from a paper co-authored by OCRA, to be released next week, which reveals that nearly half of diagnosed women don’t receive essential genetic testing, … Continued
OCRA is proud to announce the first three recipients of the $6 million we have awarded to support groundbreaking ovarian and related gynecologic cancer research in 2025. And we’re not stopping there—stay tuned as we continue to expand our investment in research this year. This is the first in a multi-part series introducing our newest … Continued
Rates of cervical precancer dropped nearly 80% between 2008 and 2022 among screened women aged 20 to 24, according to the latest Morbidity and Mortality Weekly Report from Centers for Disease Control and Prevention (CDC). The report notes that women in this age group are those most likely to have received the HPV vaccine. Read the … Continued
Join us Wednesday, April 9, 2025, for a FREE online seminar to learn about the importance of genetics and biomarkers on the treatment of endometrial cancer. This comprehensive program will cover essential topics including the difference between genetics and biomarkers, what tests are most effective in understanding treatment options, which testing is needed at diagnosis vs. recurrence, … Continued
New administrations inevitably bring changes, both big and small. The top priority of OCRA’s Policy & Advocacy team remains the same—ensuring the voices of the ovarian and gynecologic cancer community are heard and the issues that impact our community are considered. Next month, OCRA’s Advocate Leaders will convene in Washington, DC to once again bring … Continued
In a new article from TheaterMania, ovarian cancer survivor and OCRA Advocate Leader Kristen Jantonio shares how her passion for theater has been a source of strength and inspiration since being diagnosed with ovarian cancer. Through OCRA’s Advocate Leader program, she helps drive policy changes that support the gynecologic cancer community. Learn more in Playhouse Square’s Kristen … Continued
Ovarian Cancer Research Alliance (OCRA), the largest global organization dedicated to advancing ovarian and related gynecologic cancer research, announced today the recipients of two prizes awarded for noteworthy work in the field of ovarian cancer research. One honoree received the 2024 Rosalind Franklin Prize for Excellence in Ovarian Cancer Research in recognition of his groundbreaking … Continued
Recent data from the American Cancer Society’s Cancer Facts & Figures 2025 report, also covered by NPR, reveals that cancer diagnoses among younger women are increasing, with cancer incidence rates for women under 50 now 82% higher than those for men in the same age group. For more information, read “Cancer Incidence Rate for Women … Continued
OCRA Joins Forces With Rivkin Center for Ovarian Cancer Research Ovarian Cancer Research Alliance (OCRA) has announced that the Rivkin Center for Ovarian Cancer Research will join with OCRA effective April 1, 2025. This historic collaboration unites two respected organizations committed to advancing research for a cure for ovarian and all gynecologic cancers. “OCRA has always … Continued
Get email updates about research news, action alerts, and ways to join the fight.
